Poul H. Sorensen - Concepedia

Author

Poul H. Sorensen

Also Known As

David G Huntsman, David G. Huntsman, Hai-Feng Zhang, Jürgen Ruland, Lynn Smith, P H B Sorensen, P H Sorensen, P Sorensen, P. H. Sorensen, P. Sorensen

634

Publications

26.9K

Citations

H-Index

164

Concepts

All Affiliations

University of British Columbia BC Children's Hospital BC Cancer Agency University of Toronto Hospital for Sick Children

About

Poul H. Sorensen is an author at University of British Columbia specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	82	14K
2	Natural Sciences	11	11	837
3	Health Sciences	6	6	1.3K
4	Engineering	4	4	2K
5	Education	1	1	92

Poul H. Sorensen

172

Publications

24.1K

Citations

H-Index

Page 1

	Year	Citations
Single-pot, solid-phase-enhanced sample preparation for proteomics experiments Christopher S. Hughes, Sophie Moggridge, Torsten Müller, Nature Protocols Proteomic TechnologyEngineeringSample PreparationMedicineMass Spectrometry	2018	1.8K
Subgroup-specific structural variation across 1,000 medulloblastoma genomes Paul A. Northcott, David Shih, John Peacock, Nature GeneticsGenomicsCancer BiologyTumor BiologyNeuro-oncology	2012	910
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma Cristina E. Tognon, Stevan R. Knezevich, David G. Huntsman, Cancer Cell Radiation OncologyPrimary EventEtv6-ntrk3 Gene FusionMedicineCancer Genomics	2002	894
Lin28 promotes transformation and is associated with advanced human malignancies Srinivas R. Viswanathan, John T. Powers, William S. Einhorn, Nature Genetics Tumor BiologyOncologyOncogenic AgentMedicinePathology	2009	814
A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma Stevan R. Knezevich, Deborah E. McFadden, Tao Wen, Nature Genetics Congenital FibrosarcomaPathologyDisease Gene IdentificationCancer GeneticsGene Expression	1998	796
A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG Poul H. Sorensen, Stephen L. Lessnick, Dolores López‐Terrada, Nature Genetics Second EwingTranscriptional RegulationSarcoma TranslocationPathologyCancer Genetics	1994	738
<i>PAX3-FKHR</i> and <i>PAX7-FKHR</i> Gene Fusions Are Prognostic Indicators in Alveolar Rhabdomyosarcoma: A Report From the Children’s Oncology Group Poul H. Sorensen, James C. Lynch, Stephen J. Qualman, Journal of Clinical Oncology	2002	732
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors Robbie G. Majzner, Johanna Theruvath, Anandani Nellan, Clinical Cancer Research	2019	637
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 Marc Ladanyi, Man Yee Lui, Cristina R. Antonescu, Oncogene Systems BiologyTissue DevelopmentNovel GeneCancer GeneticsGene Expression	2001	614
Targeted disruption of<i>SHIP</i>leads to hemopoietic perturbations, lung pathology, and a shortened life span Cheryl D. Helgason, Jacqueline E. Damen, Patty Rosten, Genes & Development	1998	560

Page 1